Skye Bioscience Inc. Common Stock (SKYE)
Stock · NASDAQ · Health Care
$1.56as of 10/16/2026
Price chart
Active signals
SKYE Signal Track Record
How signals performed across all stocks →What SKYE's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 29 | -13.4% | 34% | September 23, 2026 |
| Bollinger Band Breakdown | 22 | -11.6% | 27% | August 6, 2026 |
| Bollinger Band Breakout | 17 | -0.1% | 47% | August 24, 2026 |
| 200-Day Moving Average TouchActive now | 5 | -23.8% | 0% | December 11, 2023 |
| Any 20-session window (baseline) | -9.5% | 34% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SKYE
Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related metabolic diseases. The company's lead clinical asset is nimacimab, a peripherally-restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1) administered as a subcutaneous injectable, which targets CB1 receptors in periphe…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 2
- Website
- skyebioscience.com/
Fundamentals
- 1-day range
- $1.54$1.6
- Market cap
- $16.58M
- P/E (trailing)
- —
- P/E (forward)
- -0.21
- EPS (trailing)
- $-7.93
- Dividend yield
- —
- Beta
- 3.13
- Avg. volume
- 89.5K
Forecasts
4 analyst ratings
Skye Bioscience Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SKYESkye Bioscience Inc. Common Stock$1.55▼ 2.52%Market cap $16.58MP/E —$1.5$13.28
- CYCNCyclerion Therapeutics Inc. Common Stock$3.36▼ 0.15%Market cap $16.67MP/E —$7.19$59.36
- MDCXMedicus Pharma Ltd. Common Stock$3.25▼ 5.25%Market cap $16.97MP/E —$0.144$2.78
- BFRIBiofrontera Inc. Common Stock$0.822▼ 2.95%Market cap $16.00MP/E —$0.555$1.66
- LPCNLipocine Inc. Common Stock$1.56▼ 7.14%Market cap $17.56MP/E —$1.59$12.37
- CTXRCitius Pharmaceuticals Inc. Common Stock$0.46▲ 0.00%Market cap $17.62MP/E —$0.46$2.19
- NCELNewcelX Ltd. Ordinary Shares$2.5▼ 12.28%Market cap $17.98MP/E —$1.83$18.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SKYE Skye Bioscience Inc. Common Stock | $16.58M | — | $1.55 | ▼ 2.52% | $1.5$13.28 |
| CYCN Cyclerion Therapeutics Inc. Common Stock | $16.67M | — | $3.36 | ▼ 0.15% | $7.19$59.36 |
| MDCX Medicus Pharma Ltd. Common Stock | $16.97M | — | $3.25 | ▼ 5.25% | $0.144$2.78 |
| BFRI Biofrontera Inc. Common Stock | $16.00M | — | $0.822 | ▼ 2.95% | $0.555$1.66 |
| LPCN Lipocine Inc. Common Stock | $17.56M | — | $1.56 | ▼ 7.14% | $1.59$12.37 |
| CTXR Citius Pharmaceuticals Inc. Common Stock | $17.62M | — | $0.46 | ▲ 0.00% | $0.46$2.19 |
| NCEL NewcelX Ltd. Ordinary Shares | $17.98M | — | $2.5 | ▼ 12.28% | $1.83$18.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Andrew J. Schwab · September 23, 2026 · Sale4.5K @ $1.61
- Andrew J. Schwab · September 23, 2026 · Sale114.9K @ $1.61
- 5AM Partners VII, LLC · September 23, 2026 · Sale4.5K @ $1.61
- 5AM Partners VII, LLC · September 23, 2026 · Sale114.9K @ $1.61
- Andrew J. Schwab · September 22, 2026 · Sale1.1K @ $1.65
- Andrew J. Schwab · September 22, 2026 · Sale27.6K @ $1.65
- 5AM Partners VII, LLC · September 22, 2026 · Sale1.1K @ $1.65
- 5AM Partners VII, LLC · September 22, 2026 · Sale27.6K @ $1.65
- Andrew J. Schwab · September 16, 2026 · Sale32.6K @ $1.91
- 5AM Partners VII, LLC · September 16, 2026 · Sale1.3K @ $1.91
- 5AM Partners VII, LLC · September 16, 2026 · Sale32.6K @ $1.91
- Andrew J. Schwab · September 16, 2026 · Sale1.3K @ $1.91
- Andrew J. Schwab · August 20, 2026 · Sale1.2K @ $0.32
- Andrew J. Schwab · August 20, 2026 · Sale6.5K @ $0.32
- Andrew J. Schwab · August 20, 2026 · Sale46 @ $0.32
Institutional Ownership
March 31, 2026
- Total shares held
- 16.12M
- Total value held
- $9.91M
- Institutional holders
- 37
- Unknown9.68M
- Unknown2.01M
- Unknown1.58M
- Unknown764.5K
- Unknown678.9K
- Unknown286.1K
- Unknown277.3K
- Unknown258.2K
- Unknown233.1K
- Unknown98.9K
See the full, filterable feed with live charts on the MarketWall dashboard.